* Getinge sees sales growth in 2014 similar to 2013
* Q4 core profit in line with forecast
* Shares rise 3.5 pct
(Adds detail, background)
STOCKHOLM, Jan 28 Swedish medical technology
firm Getinge posted a rise in fourth-quarter core
profit in line with expectations on Tuesday and said its markets
in western Europe had started to recover.
Getinge's outlook for a region that accounts for the biggest
share of its sales was a touch more positive than in October,
and its shares rose 3.5 percent by 1305 GMT, outperforming the
Stoxx Europe 600 Healthcare Index which was up 0.3
The Swedish maker of surgical theatre equipment such as
products for heart surgery and anaesthesia systems said it
expected sales growth in 2014, adjusted for currency swings and
acquisitions, to be on par with the 4.2 percent in 2013.
Earnings before interest, taxes, amortisation and
restructuring costs rose to 2.06 billion Swedish crowns ($321
million) from a year-earlier 1.94 billion. The mean forecast in
a Reuters poll of analysts was for a rise to 2.10 billion.
Getinge, whose competitors include U.S. medical technology
groups Medtronic, Stryker and Steris,
also said it saw substantial cost savings which it would present
at it capital markets day in the second quarter.
Link to full report: r.reuters.com/xem46v
($1 = 6.4312 Swedish crowns)
(Reporting by Sven Nordenstam; Editing by Niklas Pollard and